Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    19-December-2000      
Issue 250 Next Update - 14:00 UTC 08:00 EST    20-December-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Back To Vidyya Today In Vidyyasm

Vidyya Medical News Service For 20-December-2000:

The following stories appear in full on today's Vidyya Medical News Service Web site.

People with myotonic dystrophy (DM) and facioscapulohumeral dystrophy (FSHD) and their families will benefit from a new national research registry established by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Institute of Neurological Disorders and Stroke (NINDS), both parts of the National Institutes of Health (NIH).

For more information: National Registry Established For Two Muscular Dystrophy Types

Myotonic Dystrophy is an inherited disorder in which the muscles contract but have decreasing power to relax. With this condition, the muscles also become weak and waste away. Myotonic dystrophy can cause mental deficiency, hair loss and cataracts. Onset of this rare disorder commonly occurs during young adulthood.

For more information: Mytonic Dystrophy

Facioscapulohumeral muscular dystrophy (Landouzy-Déjérine disease) is an inheritable muscle disease, commonly called FSH or FSHD. Progressive weakening and loss of skeletal muscle are its major effects. It has significant medical and health impacts on individuals, families and society. Details about the nature of the disease and some basic knowledge of inheritance of genetic diseases are important to better understand FSHD.

For more information: Facioscapulohumeral Disease

There's more bad news about hormone replacement therapy this week. On the heels of estrogen being named a carcinogen by the US government, twenty years of prospective follow-up in the Nurses' Health Study show that daily estrogen doses of 0.625 mg or higher plus progestin may increase the risk of stroke by up to 45%, according to a report in the December 19th issue of the Annals of Internal Medicine.

For more information: Hormone Replacement Therapy Linked To Postmenopausal Stroke

In a genetic analysis of obese individuals, researchers have narrowed the search for the genes associated with obesity and related metabolic disorders to a small area on chromosome-3, according to a report in the Proceedings of the National Academy of Sciences for December 19.

For more information: More Obesity Genes Located

Today's Vidyya articles are:

As always, we hope you enjoy the issue.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 


Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.